SciELO - Scientific Electronic Library Online

 
vol.30 issue2Rediscovering old acquaintances: the possible role of hydroxychloroquine, chloroquine, ivermectin, and teicoplanin in the treatment of COVID-19Miastenia gravis secondary to pembrolizumab author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Revista de la OFIL

On-line version ISSN 1699-714XPrint version ISSN 1131-9429

Abstract

VARELA-REY, I et al. Galenic aspects of submucosal injection solutions for use in endoscopic polypectomy. Rev. OFIL·ILAPHAR [online]. 2020, vol.30, n.2, pp.131-139.  Epub Mar 15, 2021. ISSN 1699-714X.  https://dx.doi.org/10.4321/s1699-714x2020000200013.

Endoscopic submucosal dissection (ESD) and endoscopic mucosal resection (EMR) are the main techniques used in the removal of intestinal polyps. In both techniques a submucosal solution is injected to create a hub under the lesion that separates the mucosa from the muscular layer itself. This allows a better delimitation of the lesion and facilitates its resection.

In clinical practice, many solutions have been tested for this use, being used in most cases out off-label and without galenic, physicochemical or microbiological control, despite being parenteral administration solutions.

The objective of this study is to carry out a review of the main solutions used, as well as their limitations and the main advances made in this area.

Keywords : Submucosa; injection solution; polypectomy; endoscopic.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )